Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,847 public trials 2,102 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

NCT02071862

Conditions
Adenocarcinoma, Adenoma, Breast Diseases, +38 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Winship Cancer Institute of Emory School of Medicine Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Completed

Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer

NCT01236547

Conditions
Carcinoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
View all 130 locations
View Trial Details
Completed

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

NCT01034631

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Providence Health System: Roy and Patricia Disney Family Cancer Center Burbank, California, United States
  • Compassionate Cancer Care Medical Group, Inc. Corona, California, United States
View all 108 locations
View Trial Details
Completed

Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer

NCT01780545

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • University of Alabama Hematology Oncology Clinic at Medical West Birmingham, Alabama, United States
  • City of Hope: Duarte Duarte, California, United States
  • City of Hope: Antelope Valley Lancaster, California, United States
  • USC: Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 35 locations
View Trial Details

Related conditions